الفهرس 
Title : Outcome of Primary Posterior Tracheopexy in Thoracoscopically Repaired Esophageal Atresia Patients with Tracheomalacia
ContentsOnly 14 pages are availabe for public view
 |  | from | 181 |  |  |
| | | from | 181 | | |
Abstract
Tracheomalacia frequently develop in esophageal atresia patients
(EA)especially those with tracheoesophageal fistula (TEF). Conservative
management was the standard treatment; however, it has been reported recently
that delay in management may result in chronic lung conditions in up to one third
of the patients.
Patients and Methods: We enrolled patients presented with type-C esophageal
atresia, with concomitant moderate to severe tracheomalacia, who had their
thoracoscopic intervention done during the study period 2019-2022. We studied
the outcome of these patients in the early and intermediate post-operative period.
The outcomes were compared to a cohort with mild or no tracheomalacia, and
another cohort with tracheomalacia to whom tracheopexy was not performed to.
Results: During the allocated study period, 24 patients met the primary inclusion
criteria for tracheopexy, only 17 were included, due to early demise of the other
seven. The mean follow-up period for these patients was 26 months. Respiratory
symptoms developed in 7/17 patients in the form of cough in four patients, blue
spell in one and recurrent chest symptoms. These symptoms were attributed to
esophageal stricture as they improved after dilatation in 5 patients Moreover, two
patients developed recurrent TEF. However, only one patient had symptoms
attributed directly to residual tracheomalacia. These enrolled patients showed
similar outcome to those with no or mild tracheomalacia. There was significant
improvement in symptoms when compared to patients with tracheomalacia to
whom tracheopexy was not performed to.